» Articles » PMID: 31159624

The Impact of Whole-body Hyperthermia Interventions on Mood and Depression - Are We Ready for Recommendations for Clinical Application?

Overview
Publisher Informa Healthcare
Specialties Oncology
Pharmacology
Date 2019 Jun 5
PMID 31159624
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

To systematically summarize the findings from research studies examining the effects of whole-body hyperthermia (WBH) interventions on mood and symptoms of depression. Systematic literature search of online and offline databases (e.g., Pubmed, Web of Knowledge, Cochrane, academic libraries). Risk of bias assessment and secondary analysis of effect sizes. Clinical studies with a pre/post-intervention design and outcome measures for mood and depression as accepted in the S-3 guidelines (Association of Scientific Medical Societies in Germany). Study characteristics and outcomes (means and standard deviations) from participants receiving at least one WBH intervention. A total of 7 studies and 148 subjects with a mean age of 46 years (36-56 years) were identified. Three out of seven studies utilized hot baths and 4/7 infrared heating. Study duration ranged from 1 to 6 weeks with one or multiple interventions and an average treatment time of 66.37 min (42.55-140). Risk of bias analysis revealed small sample biases and lack of control groups in 3/7 studies. About 21 study end-points were extracted with 19 resulting in effects sizes (Cohen's ) of 0.8 or greater. Target temperatures between 38 °C and 39 °C and slower increase in core body temperature during the intervention resulted in larger treatment effects. WBH is a promising alternative treatment for depression with low risk for adverse reactions and side effects but still lacking sufficient evidence for general recommendations for clinical practice. However, as all other interventions have failed, the studies to date can provide a framework for clinical application.

Citing Articles

Hyperthermia and targeting heat shock proteins: innovative approaches for neurodegenerative disorders and Long COVID.

Smadja D, Abreu M Front Neurosci. 2025; 19:1475376.

PMID: 39967803 PMC: 11832498. DOI: 10.3389/fnins.2025.1475376.


Infrared-A to improve mood: an exploratory study of water-filtered infrared-A (wIRA) exposure.

Haggqvist I, Karha P, Kautiainen H, Snellman E, Pasternack R, Partonen T Photochem Photobiol Sci. 2024; 23(11):2045-2056.

PMID: 39441451 DOI: 10.1007/s43630-024-00650-2.


Greater severity of depressive symptoms is associated with changes to perceived sweating, preferred ambient temperature, and warmth-seeking behavior.

Tyler M, Wright B, Raison C, Lowry C, Evans L, Hale M Temperature (Austin). 2024; 11(3):266-279.

PMID: 39193043 PMC: 11346520. DOI: 10.1080/23328940.2024.2374097.


Psychotomimetic compensation versus sensitization.

Brouwer A, Carhart-Harris R, Raison C Pharmacol Res Perspect. 2024; 12(4):e1217.

PMID: 38923845 PMC: 11194300. DOI: 10.1002/prp2.1217.


Feasibility and acceptability of an integrated mind-body intervention for depression: whole-body hyperthermia (WBH) and cognitive behavioral therapy (CBT).

Mason A, Chowdhary A, Hartogensis W, Siwik C, Lupesko-Persky O, Pandya L Int J Hyperthermia. 2024; 41(1):2351459.

PMID: 38743265 PMC: 11216717. DOI: 10.1080/02656736.2024.2351459.